Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Gastrointestinal » Neoplasms 16. December 2025
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 11698  Previews Next
   
   Articles 1 - 20 / 233943  
   
PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial.
Nat Commun
Zeng L, Ruan Z, Yan H, Qin H, Zeng Z, Zou C, Huang Z, Jiang W, Dai J, Xu S, Song L, Chen Y, Zhang Y, Zeng F, Wei S, Chen S, Liu L, Xiong Y, Wang Z, Deng J, Zhang X, Sun Y, Yang D, Zhou C, Yang H, Li Y, Deng L, Xu Q, Fang C, Chen X, Wang J, Li T, Zhang G, Zhou H, Yang N, Zhang Y.
PMID: 41398162 [PubMed - as supplied by publisher]


Intergroup Randomized Phase III Study of Adjuvant FOLFIRI, FOLFOX, or 5-FU/Leucovorin for Stage II/III Rectal Cancer: ECOG-ACRIN E3201.
Oncologist
Kam AE, Zhao F, Meropol NJ, Giantonio BJ, Diasio RB, Flynn PJ, Catalano P, Hartner L, Rowland KM, Song W, Mulcahy MF, Sinicrope FA, Whitehead RP, Mayer RJ, Petrelli N, O'Dwyer PJ, Hamilton SR, Cella D, Benson AB 3rd.
PMID: 41397917 [PubMed - as supplied by publisher]


Phage Therapy in Cancer Treatment: Mechanisms, Emerging Innovations, and Translational Progress.
Crit Rev Oncol Hematol
Hsu CY, Polatova D, Hamad RH, Patel PN, Akram M, Singh G, Arora V, Nayak PP, Kadhem M, Hamzah HF.
PMID: 41397585 [PubMed - as supplied by publisher]


Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
JCO Oncol Pract
Huang AH, Lee GY, Lu CA, Sahin IH, King GT, Safyan RA, Cohen SA, Zhen DB, Shankaran V, Harris WP, Coveler AL, Malhotra J, Forbes VE, Gold PJ, Chiorean EG, Hsieh RW.
PMID: 41397186 [PubMed - as supplied by publisher]


Correction: Additional outreach effort of providing an opportunity to obtain a kit for fecal immunochemical test during the general health check-up to improve colorectal cancer screening rate in Japan: A longitudinal study.
PLoS One
PLOS One Staff.
PMID: 41396854 [PubMed - in process]


Correction: Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
PLoS One
Fan G, Zhang K, Yang X, Ding J, Wang Z, Li J.
PMID: 41396853 [PubMed - in process]


Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroups.
JNCI Cancer Spectr
Smit KC, Derksen JWG, van Lanen AS, Wesselink E, Belt EJT, Berbée M, Balen MC, Dekker JWT, van Dodewaard JM, Douma J, de Groot JW, Van Halteren HK, Hendriks MP, de Hingh IHJT, Houtsma D, Janssen JJB, Konsten JLM, Los M, Sie MPS, Sommeijer D, Tanis PJ, van der Velden A, Iersel LV, Vles WJ, de Wilt JHW, Kok DE, Kampman E, van Duijnhoven FJB, Koopman M, May AM.
PMID: 41396674 [PubMed - as supplied by publisher]


Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis.
J Oncol Pharm Pract
Beheshtirouy S, Nikniaz Z, Ghaffary S, Jaberi R, Shaseb E.
PMID: 41396594 [PubMed - as supplied by publisher]


Comparative analysis of AI-generated and deformed image registration contours on daily CBCT in prostate cancer radiation therapy: accuracy and dosimetric implications using commercial tools.
Phys Eng Sci Med
Ashburner M, Huang R, Chin J, Aly M.
PMID: 41396387 [PubMed - as supplied by publisher]


Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancer.
Mol Biomed
Fan Y, Gu X, Yang H, Chen Y, Fang C, Deng H, Dai L.
PMID: 41396345 [PubMed - indexed for MEDLINE]


Efficacy and safety of neoadjuvant therapy combined with immunotherapy in MMR‑proficient/microsatellite stable non‑metastatic rectal cancer: a systematic review and meta‑analysis.
J Cancer Res Clin Oncol
Li Y, Han C, Tang J.
PMID: 41396282 [PubMed - indexed for MEDLINE]


Diagnostic accuracy of contrast-enhanced CT for stage III gastric cancer: A prospective Chinese multicenter study.
Chin Med J (Engl)
Wang Y, Xu Z, Qu J, Liu Z, Jing C, Zang W, Zhang X, Huang Q, Wang Q, Yan S, Zhang W, Zhao G, Fu W, Yang K, Fan L, Deng J, Liang F, Wang W, You J, Li Y, Ning N, Zhao Q, Li B, Hou Y, Xu H, Chen Y, Liu S, Cui J, Zhao Z, Liao X, Jian K, Luo L, Li Y, Zhang Y, Li Z, Ji J.
PMID: 41396251 [PubMed - as supplied by publisher]


Unravelling Mechanisms of Cancer Cells' Tropism for Metastasis: A Key to Improved Cancer Therapies.
Cell Biol Int
Mallick S, Hora J, Varun TK, Shenoy P S, Bose B.
PMID: 41395724 [PubMed - indexed for MEDLINE]


Case Report: Nursing strategies for colon cancer surgery in third-trimester pregnancy.
Front Oncol
Zeng S, Chen J, Luo Y, Song D.
PMID: 41395624 [PubMed]


Gut microbiome alterations and their clinical and biological implications in ovarian cancer: a systematic review.
Front Oncol
Zhang B, Mohd Sahardi NFN, Chew KT, Di W, Shafiee MN.
PMID: 41395614 [PubMed]


Prediction of long-term survival in gastric cancer patients after immunotherapy based on CT-derived extracellular volume fraction.
Front Oncol
Wang Y, Jiang S, Yang Y, Li Y, Li Z, Lei Z, Kong X, Zhou G.
PMID: 41395607 [PubMed]


Advances in colorectal cancer screening: technological innovations, guideline discrepancies, and individualized strategies.
Front Oncol
Tang L, Zhao X, Wang G, Huang J, Zhang M, Xu W.
PMID: 41395603 [PubMed]


Beneficial impact of indocyanine green fluorescence imaging on lymphadenectomy in laparoscopic total gastrectomy for advanced upper gastric cancer.
Front Oncol
Lv CB, Tong LY, Sun YQ, Huang RJ, Han HH, Chen QX, Cai LS.
PMID: 41395601 [PubMed]


Analyzing the gut liver axis: a dual role of the microbiome in the genesis, progression, and treatment of liver cell carcinoma.
Front Microbiol
Li Q, Liu Y.
PMID: 41395459 [PubMed]


Post-ablation recurrence in hepatocellular carcinoma: molecular pathogenesis and targeted therapeutic innovations.
Am J Cancer Res
Chen J, Pang J, Wen D, Huang F, He Y, Yang H, Bai X.
PMID: 41395294 [PubMed]


   
   Articles 1 - 20 / 233943    Page 1 of 11698  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1